Tag : HempMeds

CCT Impact

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hires Gabriel Barbosa as Scientific Projects and Regulatory Developing Analyst

CCT IMPACT Agent
Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil has hired Gabriel Barbosa, MSc as the Company’s Scientific Projects and Regulatory Developing Analyst. New Frontier Data’s most recent report estimates...
CCT Impact

HempMeds®, Releases Hemp for Pets Product Line in Celebration on National Dog Day

creativemind
Medical Marijuana, Inc. (OTC: MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released its Hemp for Pets pet cannabidiol (CBD) product line in celebration of National Dog Day. Hemp for Pets...
Current News Market Watch

Medical Marijuana, Inc. Subsidiary HempMeds® Signs Agreement with National Distributor Mr. Checkout

creativemind
Medical Marijuana, Inc. (OTC:  MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® has signed an agreement with national distribution leader Mr. Checkout to distribute its line of cannabidiol (CBD) hemp oil tinctures, liquids, topical and pet products to thousands of members of national and independent retailers including natural grocery...